BCL6 and neoplasm: The results consistently demonstrated that myeloid ablation of Bcl6 remarkably precluded tumor growth in a murine subcutaneous LLC model, accompanied by the loss of Bcl6+ TAMs, a subpopulation featured with self-renewing potential, stem-related gene expression, mitochondria-dominant metabolism and pro-tumor property (Fig. S5c-h).